L’ablation par radiofréquence percutanée est un des traitements des tachycardiesventriculaires (TV). Bien que salvateur chez certains patients avec myocardiopathie (MCP),les taux de succès rapportés varient de 53 à 67% dans les centres entrainés.Le but de ce travail est d’essayer de mieux comprendre le substrat des arythmiesventriculaires et d’en améliorer le traitement. Pour cela, nous avons étudié le substrat despatients adressés pour ablation de TV (sur MCP ischémique, sur MCP dilatée à coronairessaines avec cicatrices sous épicardiques, chez les patients avec assistance ventriculairegauche et chez un patient avec syndrome de Brugada). Nous avons également évalué etproposé des outils/attitudes thérapeutiques pour essayer d’améliorer le traitement des TV.Nous avons mis en évidence des particularités électrophysiologiques pour chacun de cessubstrats qui permettent d’optimiser et d’adapter la cartographie et l’ablation chez cespatients. Par ailleurs, nous avons montré l’intérêt : (1) de nouvelles technologies pouraméliorer l’efficacité de l’ablation ; (2) des approches épicardiques ou d’alcoolisation intracoronaire, chez certains patients sélectionnés, qui permettent d’éliminer le substrat et (3)de l’imagerie cardiaque pour mieux identifier le substrat et diminuer les risques perprocédure.La connaissance du substrat spécifique à chaque pathologie, une information sur laforce du contact entre le cathéter et le tissu, l’imagerie cardiaque (scanner et IRM), uneapproche épicardique chez certains patients et l’homogénéisation de la cicatricemyocardique permettent d’être plus efficace lors de l’ablation des TV. / Radiofrequency (RF) catheter ablation is a recognized treatment for ventricular tachycardia(VT) in patients with structural heart disease. Even if it can be life saving, success rateremains around 53 to 67%.We aimed to better characterized VT substrate in patients with ischemic cardiomyopathy(CMP), non ischemic CMP with subepicardial scar, left ventricular assist device and Brugadasyndrome. We also evaluate the efficacy of new technologies (such as contact force), specificapproaches (epicardial access, intra coronary alcohol ablation), systematic use of cardiacimaging and new end-points for VT ablation.We demonstrated that each substrate had specific electrophysiological properties that helpoptimizing the mapping and the ablation in these patients. We also showed the interest of(1) new technologies to improve RF lesion formation; (2) specific approaches in selectedpatients to eradicate the VT substrate; and (3) cardiac imaging to help identifying thesubstrate and preventing complications. Finally using local abnormal ventricular potentialelimination as an end-point for VT ablation is feasible and associated with lower mortalityduring follow-up when achieved.Knowledge of substrate specificities, use of contact force, cardiac imaging, epicardial accessin selected patients and scar homogenization improve VT ablation efficacy and/or safety.

Background: This study aimed to evaluate the incremental prognostic value of infarct size, microvascular obstruction (MO), myocardial salvage index (MSI), and left ventricular ejection fraction (LV-EFCMR) assessed by cardiac magnetic resonance imaging (CMR) in comparison to traditional outcome markers in patients with ST-elevation myocardial infarction (STEMI) reperfused by primary percutaneous intervention (PCI). Methods: STEMI patients reperfused by primary PCI (n = 278) within 12 hours after symptom onset underwent CMR three days after the index event (interquartile range [IQR] two to four). Infarct size and MO were measured 15 minutes after gadolinium injection. T2-weighted and contrast-enhanced CMR were used to calculate MSI. In addition, traditional outcome markers such as ST-segment resolution, pre- and post-PCI Thrombolysis In Myocardial Infarction (TIMI)-flow, maximum level of creatine kinase-MB, TIMI-risk score, and left ventricular ejection fraction assessed by echocardiography were determined in all patients. Clinical follow-up was conducted after 19 months (IQR 10 to 27). The primary endpoint was defined as a composite of death, myocardial reinfarction, and congestive heart failure (MACE). Results: In multivariable Cox regression analysis, adjusting for all traditional outcome parameters significantly associated with the primary endpoint in univariable analysis, MSI was identified as an independent predictor for the occurrence of MACE (Hazard ratio 0.94, 95% CI 0.92 to 0.96, P <0.001). Further, C-statistics comparing a model including only traditional outcome markers to a model including CMR parameters on top of traditional outcome markers revealed an incremental prognostic value of CMR parameters (0.74 versus 0.94, P <0.001). Conclusions: CMR parameters such as infarct size, MO, MSI, and LV-EFCMR add incremental prognostic value above traditional outcome markers alone in acute reperfused STEMI.

Background: Right ventricular (RV) function is a known predictor of adverse events in heart failure and following acute myocardial infarction (AMI). While right atrial (RA) involvement is well characterized in pulmonary arterial hypertension, its relative contributions to adverse events following AMI especially in patients with heart failure and congestion need further evaluation. Methods: In this cardiovascular magnetic resonance (CMR)-substudy of AIDA STEMI and TATORT NSTEMI, 1235 AMI patients underwent CMR after primary percutaneous coronary intervention (PCI) in 15 centers across Germany (n = 795 with ST-elevation myocardial infarction and 440 with non-ST-elevation MI). Right atrial (RA) performance was evaluated using CMR myocardial feature tracking (CMR-FT) for the assessment of RA reservoir (total strain εs), conduit (passive strain εe), booster pump function (active strain εa), and associated strain rates (SR) in a blinded core-laboratory. The primary endpoint was the occurrence of major adverse cardiac events (MACE) 12 months post AMI. Results: RA reservoir (εs p = 0.061, SRs p = 0.049) and conduit functions (εe p = 0.006, SRe p = 0.030) were impaired in patients with MACE as opposed to RA booster pump (εa p = 0.579, SRa p = 0.118) and RA volume index (p = 0.866). RA conduit function was associated with the clinical onset of heart failure and MACE independently of RV systolic function and atrial fibrillation (AF) (multivariable analysis hazard ratio 0.95, 95% confidence interval 0.92 to 0.99, p = 0.009), while RV systolic function and AF were not independent prognosticators. Furthermore, RA conduit strain identified low- and high-risk groups within patients with reduced RV systolic function (p = 0.019 on log rank testing). Conclusions: RA impairment is a distinct feature and independent risk factor in patients following AMI and can be easily assessed using CMR-FT-derived quantification of RA strain.

Introdução: O miocárdio não compactado (MNC) é uma cardiomiopatia rara, cujas principais manifestações clínicas são insuficiência cardíaca, embolias e arritmias. A evolução desses pacientes é pouco conhecida. Dessa forma, o objetivo desse estudo é analisar o seguimento tardio de pacientes com MNC isolado ou associado a outras doenças, adultos e crianças com a doença, e de seus familiares, que foram acompanhados em hospital universitário de cardiologia, bem como avaliar os desfechos clínicos e de exames de imagem em cardiologia nesses pacientes. Métodos: Pacientes com diagnóstico de MNC confirmado por critérios ecocardiográficos e/ou ressonância magnética cardíaca (RMC) foram selecionados. Durante seu acompanhamento, foram convocados familiares de primeiro, segundo e terceiro graus para rastreamento da doença. Foram avaliados os seguintes desfechos: óbito, transplante cardíaco, eventos embólicos como acidente vascular cerebral (AVC) isquêmico, tromboembolismo pulmonar, embolia arterial periférica, internações hospitalares por insuficiência cardíaca (IC), ocorrência arritmias ventriculares complexas, e índices de exame de imagem como eletrocardiograma, Holter 24 horas, ecocardiograma transtorácico e RMC, que poderiam apresentar valor prognóstico nesses pacientes. Crianças (idade inferior a 12 anos) foram analisadas separadamente. Resultados: Foram acompanhados 215 pacientes com MNC, idade de 36,96 + 17,6 anos, 108 (50,2%) homens, que foram seguidos por 5,9 + 4,47 anos. Os pacientes foram divididos em 2 grupos: 193 com MNC isolado (Grupo 1) e 22 com MNC misto (associado a doenças genéticas, congênitas, doença de Chagas, coronariopatia, cardiomiopatia hipertrófica e miocardite de células gigantes; Grupo 2). A palpitação foi o sintoma clínico mais frequente, estando presente em 42,8% deles. A sobrevida foi menor nos pacientes do Grupo 2, nos que apresentaram FE do ventrículo esquerdo (VE) menor que 50% (p= 0,004), naqueles com aumento dos diâmetro e volume diastólicos finais do VE (p=0,018 e 0,017, respectivamente), com aumento do diâmetro do átrio esquerdo (p < 0,001), com disfunção diastólica do VE (p= 0,049), com disfunção sistólica do ventrículo direito (p= 0,003), nos que apresentaram internações hospitalares (p < 0,001), nos com eventos embólicos (p= 0,022), com arritmias ventriculares complexas (p= 0,010), com hipertensão arterial pulmonar pelo ecocardiograma (p < 0,001) . A ocorrência de FA foi estatisticamente significativa entre os pacientes com disfunção sistólica do VE (p= 0,0485) e todos os que apresentaram FA, tinham FEVE inferior a 40% (p= 0,048). Vinte e três pacientes eram crianças, seguidos por 4,41 ± 4,91 anos, idade média de 5,52 ± 3,62 anos, 12 (52,2%) do sexo masculino. A proporção de óbitos ou transplante cardíaco foi 3 vezes maior do que na população adulta (34,8%) e a IC foi o resultado mais comum. As arritmias cardíacas foram raras e os eventos embólicos não foram encontrados neste grupo. O rastreio familiar diagnosticou MNC em 36,7% dos pacientes. Na análise multivariada, a precocidade dos sintomas e a ocorrência de acidente vascular cerebral ou acidente isquêmico transitório foram os fatores mais importantes no prognóstico dos pacientes e capazes de predizer sobrevida (p < 0,001 e p= 0,008, respectivamente). Conclusão: O seguimento clínico e por métodos de imagens cardíacas por longo período de pacientes com MNC permite traçar um perfil dessa população e estimar o risco de complicações, reforçando a necessidade de diagnóstico e tratamento precoces. Em crianças, o MNC geralmente evolui de forma mais agressiva, com maior morbi-mortalidade. O rastreamento familiar consiste em uma ferramenta muito importante nesse contexto, permitindo a identificação de pacientes na fase subclínica da doença / Background: Non-compaction cardiomyopathy (NCC) is a rare disease, which main clinical manifestations are heart failure, arrhythmias and embolic events. The evolution of these patients is poorly known. Thus, the aims of this study was to analyze the late follow-up of patients with isolated NCC or associated with other diseases, adult and children with the disease and their relatives, which were followed at a university cardiology hospital, and to evaluate the clinical and the cardiology imaging outcomes in these patients. Methods: Patients with NCC confirmed by echocardiographic (echo) and / or cardiac magnetic resonance imaging (CMRI) criteria were selected. During their follow-up, their first, second and third degree relatives were recruited to perform screening of the disease using echo. The following variables were included: death, cardiac transplantation, embolic events such as stroke, pulmonary embolism, peripheral arterial embolism, hospital admissions for heart failure, complex ventricular arrhythmias, and imaging indexes of imaging exams such as electrocardiogram, Holter 24 hours, echocardiogram and CMRI, which could have prognostic value in these patients. Children (under 12 years old) were analyzed separately. Results: Two hundred and fifteen patients with NCC were followed for 5.9 ± 4.47 years, mean age of 36,96 ±17,6 years, 108 (50.2%) males. Patients were divided into 2 groups: 193 with isolated NCC (Group 1) and 22 with mixed NCC (associated with genetic and congenital diseases, Chagas disease, coronary disease, hypertrophic cardiomyopathy and giant cell myocarditis; Group 2). Palpitation was the most frequent clinical symptom, present in 42,8% of them. The survival rate was lower in Group 2 patients (p < 0.05), left ventricular (LV) ejection fraction (EF) less than 50% (p= 0.004), increased LV end-diastolic diameter and volume by echo (p= 0.018 and 0.017, respectively), with LV diastolic dysfunction (p= 0.049), with increased left atrium dimensions (p < 0,001), with right ventricular systolic dysfunction (p= 0.003), hospital admissions (p < 0.001), embolic events (p= 0.022), complex ventricular arrhythmias (p = 0.010) and pulmonary hypertension by echo (p < 0.001). All patients with isolated NCC and AF presented LVEF less than 0.40, and between patients without AF, only 41.7% presented LVEF less than 0.40 (p = 0.048). Twenty-three patients was children, followed for 4.41 ± 4.91 years, mean age of 5.52 ± 3.62 years, 12 (52.2%) males. The proportion of deaths or cardiac transplantation was 3 times higher than in the adult population (34,8%) and heart failure was the most common outcome. Cardiac arrhythmias were rare, and the embolic events were not found in this group. The familiar screening diagnosed NCC in 36.7% of the patients. In the multivariate analysis, the precocity of the symptoms and the occurrence of stroke or transient ischemic attack were the most important factors in the prognosis of this patients and it is able to predict survival (p < 0.001 and p= 0.008, respectively). Conclusion: The clinical and cardiac imaging methods allows us to draw a profile of this population and to estimate the risk of complications, emphasizing the need for early diagnosis and treatment. In children, NCC used to develop more severe disease. Family screening is a very important tool, allowing the identification of patients with subclinical stage of the disease

Introdução: O miocárdio não compactado (MNC) é uma cardiomiopatia rara, cujas principais manifestações clínicas são insuficiência cardíaca, embolias e arritmias. A evolução desses pacientes é pouco conhecida. Dessa forma, o objetivo desse estudo é analisar o seguimento tardio de pacientes com MNC isolado ou associado a outras doenças, adultos e crianças com a doença, e de seus familiares, que foram acompanhados em hospital universitário de cardiologia, bem como avaliar os desfechos clínicos e de exames de imagem em cardiologia nesses pacientes. Métodos: Pacientes com diagnóstico de MNC confirmado por critérios ecocardiográficos e/ou ressonância magnética cardíaca (RMC) foram selecionados. Durante seu acompanhamento, foram convocados familiares de primeiro, segundo e terceiro graus para rastreamento da doença. Foram avaliados os seguintes desfechos: óbito, transplante cardíaco, eventos embólicos como acidente vascular cerebral (AVC) isquêmico, tromboembolismo pulmonar, embolia arterial periférica, internações hospitalares por insuficiência cardíaca (IC), ocorrência arritmias ventriculares complexas, e índices de exame de imagem como eletrocardiograma, Holter 24 horas, ecocardiograma transtorácico e RMC, que poderiam apresentar valor prognóstico nesses pacientes. Crianças (idade inferior a 12 anos) foram analisadas separadamente. Resultados: Foram acompanhados 215 pacientes com MNC, idade de 36,96 + 17,6 anos, 108 (50,2%) homens, que foram seguidos por 5,9 + 4,47 anos. Os pacientes foram divididos em 2 grupos: 193 com MNC isolado (Grupo 1) e 22 com MNC misto (associado a doenças genéticas, congênitas, doença de Chagas, coronariopatia, cardiomiopatia hipertrófica e miocardite de células gigantes; Grupo 2). A palpitação foi o sintoma clínico mais frequente, estando presente em 42,8% deles. A sobrevida foi menor nos pacientes do Grupo 2, nos que apresentaram FE do ventrículo esquerdo (VE) menor que 50% (p= 0,004), naqueles com aumento dos diâmetro e volume diastólicos finais do VE (p=0,018 e 0,017, respectivamente), com aumento do diâmetro do átrio esquerdo (p < 0,001), com disfunção diastólica do VE (p= 0,049), com disfunção sistólica do ventrículo direito (p= 0,003), nos que apresentaram internações hospitalares (p < 0,001), nos com eventos embólicos (p= 0,022), com arritmias ventriculares complexas (p= 0,010), com hipertensão arterial pulmonar pelo ecocardiograma (p < 0,001) . A ocorrência de FA foi estatisticamente significativa entre os pacientes com disfunção sistólica do VE (p= 0,0485) e todos os que apresentaram FA, tinham FEVE inferior a 40% (p= 0,048). Vinte e três pacientes eram crianças, seguidos por 4,41 ± 4,91 anos, idade média de 5,52 ± 3,62 anos, 12 (52,2%) do sexo masculino. A proporção de óbitos ou transplante cardíaco foi 3 vezes maior do que na população adulta (34,8%) e a IC foi o resultado mais comum. As arritmias cardíacas foram raras e os eventos embólicos não foram encontrados neste grupo. O rastreio familiar diagnosticou MNC em 36,7% dos pacientes. Na análise multivariada, a precocidade dos sintomas e a ocorrência de acidente vascular cerebral ou acidente isquêmico transitório foram os fatores mais importantes no prognóstico dos pacientes e capazes de predizer sobrevida (p < 0,001 e p= 0,008, respectivamente). Conclusão: O seguimento clínico e por métodos de imagens cardíacas por longo período de pacientes com MNC permite traçar um perfil dessa população e estimar o risco de complicações, reforçando a necessidade de diagnóstico e tratamento precoces. Em crianças, o MNC geralmente evolui de forma mais agressiva, com maior morbi-mortalidade. O rastreamento familiar consiste em uma ferramenta muito importante nesse contexto, permitindo a identificação de pacientes na fase subclínica da doença / Background: Non-compaction cardiomyopathy (NCC) is a rare disease, which main clinical manifestations are heart failure, arrhythmias and embolic events. The evolution of these patients is poorly known. Thus, the aims of this study was to analyze the late follow-up of patients with isolated NCC or associated with other diseases, adult and children with the disease and their relatives, which were followed at a university cardiology hospital, and to evaluate the clinical and the cardiology imaging outcomes in these patients. Methods: Patients with NCC confirmed by echocardiographic (echo) and / or cardiac magnetic resonance imaging (CMRI) criteria were selected. During their follow-up, their first, second and third degree relatives were recruited to perform screening of the disease using echo. The following variables were included: death, cardiac transplantation, embolic events such as stroke, pulmonary embolism, peripheral arterial embolism, hospital admissions for heart failure, complex ventricular arrhythmias, and imaging indexes of imaging exams such as electrocardiogram, Holter 24 hours, echocardiogram and CMRI, which could have prognostic value in these patients. Children (under 12 years old) were analyzed separately. Results: Two hundred and fifteen patients with NCC were followed for 5.9 ± 4.47 years, mean age of 36,96 ±17,6 years, 108 (50.2%) males. Patients were divided into 2 groups: 193 with isolated NCC (Group 1) and 22 with mixed NCC (associated with genetic and congenital diseases, Chagas disease, coronary disease, hypertrophic cardiomyopathy and giant cell myocarditis; Group 2). Palpitation was the most frequent clinical symptom, present in 42,8% of them. The survival rate was lower in Group 2 patients (p < 0.05), left ventricular (LV) ejection fraction (EF) less than 50% (p= 0.004), increased LV end-diastolic diameter and volume by echo (p= 0.018 and 0.017, respectively), with LV diastolic dysfunction (p= 0.049), with increased left atrium dimensions (p < 0,001), with right ventricular systolic dysfunction (p= 0.003), hospital admissions (p < 0.001), embolic events (p= 0.022), complex ventricular arrhythmias (p = 0.010) and pulmonary hypertension by echo (p < 0.001). All patients with isolated NCC and AF presented LVEF less than 0.40, and between patients without AF, only 41.7% presented LVEF less than 0.40 (p = 0.048). Twenty-three patients was children, followed for 4.41 ± 4.91 years, mean age of 5.52 ± 3.62 years, 12 (52.2%) males. The proportion of deaths or cardiac transplantation was 3 times higher than in the adult population (34,8%) and heart failure was the most common outcome. Cardiac arrhythmias were rare, and the embolic events were not found in this group. The familiar screening diagnosed NCC in 36.7% of the patients. In the multivariate analysis, the precocity of the symptoms and the occurrence of stroke or transient ischemic attack were the most important factors in the prognosis of this patients and it is able to predict survival (p < 0.001 and p= 0.008, respectively). Conclusion: The clinical and cardiac imaging methods allows us to draw a profile of this population and to estimate the risk of complications, emphasizing the need for early diagnosis and treatment. In children, NCC used to develop more severe disease. Family screening is a very important tool, allowing the identification of patients with subclinical stage of the disease

Die kardiale Magnetresonanztomographie (MRT) ermöglicht nach einem akuten Myokardinfarkt (AMI) die Visualisierung und Quantifizierung der Myokardschädigung anhand verschiedener Parameter wie Ejektionsfraktion (EF), Infarktgröße, Mikrovaskuläre Obstruktion (MO) und „Myocardial Salvage Index“ (MSI). Anhand dieser MRT-Marker kann das Risiko für kardiovaskuläre Komplikationen eingeschätzt werden, was für die Weiterversorgung des Patienten sowie für die kardiologische Forschung von großem Interesse ist. In dieser Arbeit wurde die prognostische Relevanz der MRT-Parameter erstmals in einer großen, multizentrischen Studie untersucht. Zudem sollte unter den vier genannten MRT-Markern derjenige mit der größten prognostischen Aussagekraft ermittelt werden. Dazu wurden 795 Patienten aus der AIDA STEMI Studie einer MRT unterzogen und dann zwölf Monate lang im Hinblick auf den kombinierten Endpunkt „Major Adverse Cardiac Events“ (MACE; bestehend aus Tod, Reinfarkt und Klinikaufnahme wegen Herzinsuffizienz) nachbeobachtet. Die Ergebnisse belegen, dass die genannten MRT-Parameter prognostisch relevant sind und insbesondere die MO und die Infarktgröße einen Einfluss auf die Prognose ausüben, welcher über den Wert etablierter klinischer Risikomarker hinausgeht. Herausragende Bedeutung kommt dabei der MO zu, welche nach multivariater Analyse der potenteste MRT-Prädiktor für kardiovaskuläre Ereignisse ist. Somit sollten die MRT-Parameter in kommenden kardiologischen Studien als Surrogatmarker für klinische Endpunkte berücksichtigt werden. Zudem könnten sie für den klinischen Alltag die Möglichkeit bieten, die Patientenversorgung enger an die individuelle Prognose anzupassen.

L'Imagerie par Résonance Magnétique pondérée en Diffusion (IRM-D) permet l'accès à l'information structurelle des tissus au travers de la lecture du mouvement brownien des molécules d'eau. Ses applications sont nombreuses en imagerie cérébrale, tant en milieu clinique qu'en recherche. Néanmoins le mouvement physiologique créé une perte de signal supplémentaire au cours de l'encodage de la diffusion. Cette perte de signal liée au mouvement limite les applications de l'IRM-D quant à l'imagerie cardiaque. L'utilisation de faibles valeurs de pondération (b) réduit cette sensibilité mais permet seulement l'imagerie du mouvement incohérent intra-voxel (IVIM) qui contient la circulation sanguine et la diffusion des molécules d'eau. L'imagerie IVIM possède pourtant de nombreuses applications en IRM de l'abdomen, depuis la caractérisation tissulaire à la quantification de la perfusion, mais reste inexplorée pour l'imagerie du coeur. Mon travail de thèse correspond à l'évaluation des conditions d'application de l'IRM-D à faibles valeurs de b pour le coeur humain, afin de proposer des contributions méthodologiques et d'appliquer les techniques développées expérimentalement. Nous avons identifié le mouvement cardiaque comme une des sources majeures de perte de signal. Bien que le mouvement global puisse être corrigé par un recalage non-rigide, la perte de signal induite par le mouvement perdure et empêche l'analyse précise par IRM-D du myocarde. L'étude de cette perte de signal chez un volontaire a fourni une fenêtre temporelle durable où le mouvement cardiaque est au minimum en diastole. Au sein de cette fenêtre optimale, la fluctuation de l'intensité atteste d'un mouvement variable résiduel. Une solution de répéter les acquisitions avec un déclenchement décalé dans le temps permet la capture des minimas du mouvement, c.-à-d. des maximas d'intensité en IRM-D. La projection du maximum d'intensité dans le temps (TMIP) permet ensuite de récupérer des images pondérées en diffusion avec un minimum de perte de signal lié au mouvement. Nous avons développé et évalué différentes séquences d'acquisition combinées avec TMIP : la séquence d'imagerie écho-planaire classique par écho de spin (SE-EPI) peut être adaptée mais souffre du repliement d'image ; une séquence Carr-Purcell-Meiboom-Gill combinée avec une préparation d'encodage de diffusion est plus robuste aux distorsions spatiales mais des artefacts de bandes noires empêchent son applicabilité ; finalement une séquence double-SE-EPI compensant les courants de Foucault et pleinement optimisée produit des images IRM-D moins artefactées. Avec cette séquence, l'IRM-D-TMIP permet la réduction significative de la perte de signal liée au mouvement pour l'imagerie cardiaque pondérée en diffusion. L'inconvénient avec TMIP vient de l'amplification du bruit positif d'intensité. Afin de compenser cette sensibilité du TMIP, nous séparons le bruit d'intensité des fluctuations lentes liées au mouvement grâce à une nouvelle approche basée sur l'analyse en composantes principales (PCA). La décomposition préserve les détails anatomiques tout en augmentant les rapports signal et contraste-à-bruit (SNR, CNR). Avec l'IRM-D-PCATMIP, nous augmentons à la fois l'intensité finale et la qualité d'image (SNR) en théorie et expérimentalement. Les bénéfices ont été quantifiés en simulation avant d'être validés sur des volontaires. De plus la technique a montré des résultats reproductibles sur des patients post-infarctus aigue du myocarde, avec un contraste cohérent avec la position et l'étendue de la zone pathologique. Contrairement à l'imagerie cérébrale, l'imagerie IRM-D par faibles valeurs de pondération in vivo doit être différentiée des analyses IRM-D ex-vivo. Ainsi l'IRM-D-PCATMIP offre une technique sans injection pour l'exploration du myocarde par imagerie IVIM. Les premiers résultats sont encourageants pour envisager l'application sur un modèle expérimental d'une maladie cardiovasculaire [etc...] / Diffusion weighted magnetic resonance imaging (DW-MRI, or DWI) enables the access to the structural information of body tissues through the reading of water molecules Brownian motion. Its applications are many in brain imaging, from clinical practice to research. However physiological motion induces an additional signal-loss when diffusion encoding is applied. This motion-induced signal-loss limits greatly its applications in cardiac imaging. Using low diffusion-weighting values (b) DWI reduces this sensitivity but permits only the imaging of intravoxel incoherent motion (IVIM), which combines both water diffusion and perfusion. IVIM imaging has many applications in body MRI, from tissue characterization to perfusion quantification but remains unexplored for the imaging of the heart. The purpose of this work was to evaluate the context of low b-values DWI imaging of the heart, propose methodological contributions and then apply the developed techniques experimentally. We identified cardiac motion as one of the major sources of motion-induced signal loss. Although bulk motion can be corrected with a non-rigid registration algorithm, additional signal-loss remains uncorrected for and prevents accurate DWI of the myocardium. The study of diffusion-weighted signal-loss induced by cardiac motion in a volunteer provided a time-window when motion is at minimum in diastole. Within this optimal time-window, fluctuation of intensity attests of variable remaining physiological motion. A solution to repeat acquisition with shifted trigger-times ease the capture of motion amplitude minima, i.e. DWI-intensity maxima. Temporal maximum intensity projection (TMIP) finally retrieves diffusion weighted images of minimal motion-induced signal-loss. We evaluated various attempts of sequence development with TMIP: usual spin-echo echo-planar imaging (se-EPI) sequence can be improved but suffers aliasing issues; a balanced steady-state free-precession (b-SSFP) combined with a diffusion preparation is more robust to spatial distortions but typical banding artifacts prevent its applicability; finally a state-of-the-art double-spin-echo EPI sequence produces less artifacted DWI results. With this sequence, TMIP-DWI proves to significantly reduce motion-induced signal-loss in the imaging of the myocardium. The drawback with TMIP comes from noise spikes that can easily be highlighted. To compensate for TMIP noise sensitivity, we separated noise spikes from smooth fluctuation of intensity using a novel approach based on localized principal component analysis (PCA). The decomposition was made so as to preserve anatomical features while increasing signal and contrast to noise ratios (SNR, CNR). With PCATMIP-DWI, both signal-intensity and SNR are increased theoretically and experimentally. Benefits were quantified in a simulation before being validated in volunteers. Additionally the technique showed reproducible results in a sample of acute myocardial infarction (AMI) patients, with a contrast matching the extent and location of the injured area. Contrarily to brain imaging, in vivo low b-values DWI should be differentiated from ex vivo DWI pure diffusion measurements. Thus PCATMIP-DWI might provide an injection-free technique for exploring cardiac IVIM imaging. Early results encourage the exploration of PCATMIP-DWI in an experimental model of cardiac diseases. Moreover the access to higher b values would permit the study of the full IVIM model for the human heart that retrieves and separates both perfusion and diffusion information

No description available.

Cette thèse porte sur la caractérisation cardiaque, qui représente un enjeu méthodologique et clinique important, à la fois pour améliorer le diagnostic des pathologies et optimiser les moyens de traitement. Des méthodes de recalage et de fusion de données sont proposées pour amener dans un même référentiel des images IRM, scanner, échographiques et électro-anatomiques et ainsi décrire le cœur suivant des caractéristiques anatomiques, électriques, mécaniques et tissulaires. Les méthodes proposées pour recaler des données multimodales reposent sur deux processus principaux : l'alignement temporel et le recalage spatial. Les dimensions temporelles des images considérées sont mises en synchronisées par une méthode de déformation temporelle dynamique adaptative. Celle-ci permet de compenser les modifications temporelles non-linéaires entre les différentes acquisitions. Pour le recalage spatial, des méthodes iconiques ont été développées pour corriger les artefacts de mouvements dans les séquences ciné-IRM, pour recaler les séquences ciné-IRM avec les séquences d'IRM de rehaussement tardif et pour recaler les ciné-IRM avec les images scanner. D'autre part, une méthode basée contours, développée dans un précédent travail, a été améliorée pour prendre en compte des acquisitions échographiques multi-vues. Ces méthodes ont été évaluées sur données réelles pour sélectionner les métriques les plus adaptées et pour quantifier les performances des approches iconiques et pour estimer la précision du recalage entre échographies et ciné-IRM. Ces méthodes sont appliquées à la caractérisation de cardiomyopathies hypertrophiques (CMH) et d'asynchronismes cardiaques. Pour la CMH, l'objectif était de mieux interpréter les données échographiques par la fusion de l'information de fibrose issue de l'IRM de rehaussement tardif avec l'information mécanique issue de l'échographie de speckle tracking. Cette analyse a permis d'évaluer le strain régional en tant qu'indicateur de la présence locale de fibrose. Concernant l'asynchronisme cardiaque, nous avons établi une description du couplage électromécanique local du ventricule gauche par la fusion de données échographiques, électro-anatomiques, scanner et, dans les cas appropriés, d'IRM de rehaussement tardif. Cette étude de faisabilité ouvre des perspectives pour l'utilisation de nouveaux descripteurs pour la sélection des sites de stimulation optimaux pour la thérapie de resynchronisation cardiaque. / This work concerns cardiac characterization, a major methodological and clinical issue, both to improve disease diagnostic and to optimize its treatment. Multisensor registration and fusion methods are proposed to bring into a common referential data from cardiac magnetic resonance (CMRI), dynamic cardiac X-ray computed tomography (CT), speckle tracking echocardiography (STE) and electro-anatomical mappings of the inner left ventricular chamber (EAM). These data is used to describe the heart by its anatomy, electrical and mechanical function, and the state of the myocardial tissue. The methods proposed to register the multimodal datasets rely on two main processes: temporal registration and spatial registration. The temporal dimensions of input data (images) are warped with an adaptive dynamic time warping (ADTW) method. This method allowed to handle the nonlinear temporal relationship between the different acquisitions. Concerning the spatial registration, iconic methods were developed, on the one hand, to correct for motion artifacts in cine acquisition, to register cine-CMRI and late gadolinium CMRI (LGE-CMRI), and to register cine-CMRI with dynamic CT. On the other hand, a contour-based method developed in a previous work was enhanced to account for multiview STE acquisitions. These methods were evaluated on real data in terms of the best metrics to use and of the accuracy of the iconic methods, and to assess the STE to cine-CMRI registration. The fusion of these multisensor data enabled to get insights about the diseased heart in the context of hypertrophic cardiomyopathy (HCM) and cardiac asynchronism. For HCM, we aimed to improve the understanding of STE by fusing fibrosis from LGE-CMRI with strain from multiview 2D STE. This analysis allowed to assess the significance of regional STE strain as a surrogate of the presence of regional myocardial fibrosis. Concerning cardiac asynchronism, we aimed to describe the intra-segment electro-mechanical coupling of the left ventricle using fused data from STE, EAM, CT and, if relevant, from LGE-CMRI. This feasibility study provided new elements to select the optimal sites for LV stimulation.

Les maladies cardiovasculaires et en particulier les maladies coronariennes représentent la principale cause de mortalité mondiale avec 17,9 millions de décès en 2012. L’IRM cardiaque est un outil particulièrement intéressant pour la compréhension et l’évaluation des cardiopathies, notamment ischémiques. Son apport diagnostique est souvent majeur et elle apporte des informations non accessibles par d’autres modalités d’imagerie. Les travaux menés pendant cette thèse portent plus particulièrement sur l’examen dit de perfusion myocardique qui consiste à étudier la distribution d’un agent de contraste au sein du muscle cardiaque lors de son premier passage. En pratique clinique cet examen est souvent limité à la seule analyse visuelle du clinicien qui recherche un hyposignal lui permettant d’identifier l’artère coupable et d’en déduire le territoire impacté. Cependant, cette technique est relative et ne permet pas de quantifier le flux sanguin myocardique. Au cours de ces dernières années, un nombre croissant de techniques sont apparues pour permettre cette quantification et ce à toutes les étapes de traitement, depuis l’acquisition jusqu’à la mesure elle-même. Nous avons dans un premier temps établi un pipeline de traitement afin de combiner ces approches et de les évaluer à l’aide d’un fantôme numérique et à partir de données cliniques. Nous avons pu démontrer que l’approche Bayésienne permettait de quantifier la perfusion cardiaque et sa supériorité à évaluer le délai d’arrivé du bolus d’indicateur par rapport au modèle de Fermi. De plus l’approche Bayésienne apporte en supplément des informations intéressantes telles que la fonction de densité de probabilité de la mesure et l’incertitude sur la fonction résidu qui permettent de connaitre la fiabilité de la mesure effectuée notamment en observant la répartition de la fonction de densité de probabilité de la mesure. Enfin, nous avons proposé un algorithme de segmentation des lésions myocardiques, exploitant les dimensions spatiotemporelles des données de perfusion. Cette technique permet une segmentation objective et précise de la région hypoperfusée permettant une mesure du flux sanguin myocardique sur une zone de tissu dont le comportement est homogène et dont la mesure du signal moyen permet une augmentation du rapport contraste à bruit. Sur la cohorte de 30 patients, la variabilité des mesures du flux sanguin myocardique effectuées sur les voxels détectés par cette technique était significativement inférieure à celle des mesures effectuées sur les voxels des zones définies manuellement (différence moyenne=0.14, 95% CI [0.07, 0.2]) et de celles effectuées sur les voxels des zones définies à partir de la méthode bullseye (différence moyenne =0.25, 95% CI [0.17, 0.36]) / Cardiovascular diseases and in particular coronary heart disease are the main cause of death worldwide with 17.9 million deaths in 2012. Cardiac MRI is a particularly interesting tool for understanding and evaluating heart disease, including ischemic heart disease. Its diagnostic contribution is often major and it provides information that is not accessible by other imaging modalities. The work carried out during this thesis focuses more specifically on the so-called myocardium perfusion test, which consists in studying the distribution of a contrast agent within the heart muscle during its first passage. In clinical practice, this examination is often limited to the clinician's visual analysis, allowing him to identify the culprit artery and deduce the impacted territory. However, this technique is relative and does not quantify myocardial blood flow. In recent years, an increasing number of techniques have emerged to enable this quantification at all stages of processing, from acquisition to the measurement itself. We first established a treatment pipeline to combine these approaches and evaluate them using a digital phantom and clinical data. We demonstrated that the Bayesian approach is able to quantify myocardium perfusion and its superiority in evaluating the arrival time of the indicator bolus compared to the Fermi model. In addition, the Bayesian approach provides additional interesting information such as the probability density function of the measurement and the uncertainty of the residual function, which makes it possible to know the reliability of the measurement carried out, in particular by observing the distribution of the probability density function of the measurement. Finally, we proposed an algorithm for segmentation of myocardial lesions, using the spatial and temporal dimensions of infusion data. This technique allows an objective and precise segmentation of the hypoperfused region allowing a measurement of myocardial blood flow over an area of tissue which behavior is homogeneous and which average signal measurement allows an increase in the contrast-to-noise ratio. In the cohort of 30 patients, the variability of myocardial blood flow measurements performed on voxels detected by this technique was significantly lower than that of measurements performed on voxels in manually defined areas (mean difference=0.14, 95% CI[0.07, 0.2]) and those performed on voxels in areas defined using the bullseye method (mean difference=0.25, 95% CI[0.17, 0.36])